Contraline Closes $10.7 Million Series A Financing To Become A Clinical Stage Company
Amount Raised
$10.7 Million
Round Type
Series A
CharlottesvilleOtherBiotechnologyMobileCommerce And ShoppingClothing And ApparelDescription
Contraline, Inc., a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective male contraception, has closed $10.7 million in its Series A financing. The financing round was led by MBX Capital, a venture capital firm that invests in early-stage healthcare and life sciences companies. Additional investors in Contraline include: Rhia Ventures, ShangBay Capital, Founders Fund, Metaplanet Holdings, Graphene Ventures, Smith Ventures, Jaffray Woodriff, and Jason Calacanis.
Who to call at Contraline, and when
A new round usually means Contraline is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Contraline raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Contraline, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Contraline raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansContraline raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.